Latest research report on “Drugs for Malaria Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5563099
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician’s prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
This report contains market size and forecasts of Drugs for Malaria in Global, including the following market information:
Global Drugs for Malaria Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs for Malaria market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Aryl Aminoalcohol Compounds Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Malaria include Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Malaria companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Malaria Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Malaria Market Segment Percentages, by Type, 2021 (%)
– Aryl Aminoalcohol Compounds
– Antifolate Compounds
– Artemisinin Compounds
Global Drugs for Malaria Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Malaria Market Segment Percentages, by Application, 2021 (%)
Global Drugs for Malaria Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Malaria Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Drugs for Malaria revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs for Malaria revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Guilin Pharmaceutical
– IPCA Laboratories
– Mylan Labs
– Sanofi Aventis
– Ajanta Pharma
More information about Discount offers (20% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5563099
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441